hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC

Trono, P., Tocci, A., Palermo, B., Di Carlo, A., D'Ambrosio, L., D'Andrea, D. ORCID: 0000-0002-7843-3856, Di Modugno, F., De Nicola, F., Goeman, F., Corleone, G., Warren, S., Paolini, F., Panetta, M., Sperduti, I., Baldari, S., Visca, P., Carpano, S., Cappuzzo, F., Russo, V., Tripodo, C., Zucali, P., Gregorc, V., Marchesi, F. and Nistico, P., 2023. hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC. Journal for ImmunoTherapy of Cancer, 11 (8): e006913. ISSN 2051-1426

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Journal for ImmunoTherapy of Cancer
Creators:	Trono, P., Tocci, A., Palermo, B., Di Carlo, A., D'Ambrosio, L., D'Andrea, D., Di Modugno, F., De Nicola, F., Goeman, F., Corleone, G., Warren, S., Paolini, F., Panetta, M., Sperduti, I., Baldari, S., Visca, P., Carpano, S., Cappuzzo, F., Russo, V., Tripodo, C., Zucali, P., Gregorc, V., Marchesi, F. and Nistico, P.
Publisher:	BMJ
Date:	23 August 2023
Volume:	11
Number:	8
ISSN:	2051-1426
Identifiers:	Number Type 10.1136/jitc-2023-006913 DOI 1873583 Other
Rights:	This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
Divisions:	Schools > School of Science and Technology
Record created by:	Jeremy Silvester
Date Added:	14 Mar 2024 10:04
Last Modified:	14 Mar 2024 10:04
URI:	https://irep.ntu.ac.uk/id/eprint/51077

Actions (login required)

Edit View

Views

Downloads